Who is sponsoring EUROCONDOR?

EUROCONDOR is sponsored by BCN Peptides.

What condition does EUROCONDOR study?

EUROCONDOR studies Diabetic Retinopathy.

What drugs are being tested in EUROCONDOR?

Interventions: COLIRIOBCN070660, Placebo, Brimonidine.

What is the status of EUROCONDOR?

EUROCONDOR is currently COMPLETED.

Last reviewed 2016-01-11 · How we verify

Neurodegeneration as Early Event in Pathogenesis of Diabetic Retinopathy:Multicentric, Prospective, Ph. II-III,Random.Controlled Trial to Assess Efficacy of Neuroprotective Drugs Administered Topically to Prevent/Arrest Diabetic Retinopathy (EUROCONDOR)

NCT01726075 Phase 2/Phase 3 COMPLETED

To assess whether neuroprotective drugs administered topically (somatostatin and brimonidine) are able to prevent or arrest the development and progression of neurodegenerative changes

Details

Lead sponsor	BCN Peptides
Phase	Phase 2/Phase 3
Status	COMPLETED
Enrolment	450
Start date	2013-02
Completion	2015-11

Conditions

Diabetic Retinopathy

Interventions

COLIRIOBCN070660
Placebo
Brimonidine

Primary outcomes

Changes in the Implicit Time assessed by mfERG (IT-mfERG) at month 6, 12, 18 and 24 — month 24

Countries

Denmark, France, Germany, Italy, Portugal, Spain, United Kingdom